VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $983 | +818.7% | 71,703 | +964.6% | 0.00% | – |
Q2 2023 | $107 | +25.9% | 6,735 | -38.6% | 0.00% | – |
Q1 2023 | $85 | -66.8% | 10,972 | -17.4% | 0.00% | – |
Q4 2022 | $256 | -99.9% | 13,279 | +32.5% | 0.00% | – |
Q3 2022 | $214,000 | +2277.8% | 10,025 | +1340.4% | 0.00% | – |
Q2 2022 | $9,000 | -83.0% | 696 | -68.7% | 0.00% | – |
Q1 2022 | $53,000 | – | 2,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |